ID
36393
Descripción
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (at least 21 days before dosing) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (7-14 days after last dose) This document contains the concomitant medication form. It has to be filled in if the subject takes concomitant medication during the study.
Palabras clave
Versiones (2)
- 5/9/17 5/9/17 -
- 10/5/19 10/5/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
10 de mayo de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole in healthy adults, 101468/201
Concomitant Medication
- StudyEvent: ODM
Descripción
CONCOMITANT MEDICATION
Alias
- UMLS CUI-1
- C2347852
Descripción
If ‘Yes’, please record all medications below. When appropriate, medical conditions should be recorded on the Adverse Event form, utilising the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2347852
Descripción
(Trade name preferred)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
Single dose/unit
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1960417
Descripción
dose frequency
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826654
Descripción
Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Indication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3146298
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0013227
Descripción
00.00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0013227
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Descripción
00:00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C0013227
Similar models
Concomitant Medication
- StudyEvent: ODM
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])